Monopar Therapeutics

MNPRCIK 0001645469 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 1, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0064

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 29, 20267.01 · Regulation FD Disclosure9.01 · Financial Statements and Exhibits May 19, 2026no items parsed May 14, 2026no items parsed Apr 20, 2026no items parsed Mar 27, 2026no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Monopar Therapeutics

Name	Roles	Filings
Anderson Raymond	Director	11
Brown Michael J	Director	11
Mazar Andrew Paul	OfficerDirector	6
Rioux Patrice	-	5
Vu Quan Anh	Officer	3

Showing 6-10 of 17

Per pagePrevPage 2 of 4Next

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Monopar Therapeutics. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#	Insider	Trades	Win rate	Avg	Median	Best	Worst
1	Robinson Chandler	3	67%	-39.0%	+3.5%	+12.9%	-133.4%
2	Cittadine Andrew	10	20%	-19.6%	-22.5%	+17.1%	-47.5%

All filings

128 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Apr 2, 2026	Cittadine Andrew Chief Operating Officer	FTax	1,571	$54.79	$86,075
Apr 2, 2026	Robinson Chandler Chief Executive Officer · Director	FTax	1,972	$54.79	$108,046
Mar 4, 2026	Rodriguez Susan CCSO	Holdings only	-	-	-
Jan 30, 2026	Robinson Chandler Chief Executive Officer · Director	JOther	62,815	$0.00	$0
Jan 5, 2026	Rioux Patrice Other	Holdings only	-	-	-

Showing 1-5 of 128

Per pagePage 1 of 26Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value